Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Rang in aandelen #29826
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Aandeelprijs
$7.00
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$19.47M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-35.19%
Land
CA
Handel Devonian Health Group Inc. (DVHGF)

Categorie

Aandelsplitsingen voor Devonian Health Group Inc. (DVHGF)
Het aandeel Devonian Health Group Inc. (symbool: DVHGF) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 19, 2026.
Eén aandeel DVHGF dat vóór Aug 19, 2026 werd gekocht, staat nu gelijk aan 0 aandelen DVHGF.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR